Rishi's experience spans machine learning, immuno-oncology, and drug development. He leads Centivax’s computational science efforts and is developing machine learning methods for antibody engineering.
At Y-Trap, he spearheads the development of multifunctional fusion proteins for cancer immunotherapy — leading to multiple internal programs advancing towards clinical development, as well as a partnership with Merck KGaA, Darmstadt, Germany. Previously, he built the machine learning team at Herophilus (fka System1 Biosciences), leading the analysis of multi-omics and imaging datasets to identify deep phenotypes of neuropsychiatric diseases in cerebral organoids. He earned his BS and MS in Computer Science at Stanford, where he developed machine learning methods for structural biology in Ron Dror's group and started a class on space policy.